Markets
GM logo General Motors Chevrolet
(Artur Widak/Getty Images)

GM’s 2024 surge stalls following Trump’s tariff threat

Over the last 12 months the stock has nearly doubled.

Automakers Ford and General Motors are getting buffeted Monday by President-elect Donald Trump’s tweeted tariff threats Tuesday against Mexico, Canada, and China.

It makes sense, seeing as the companies’ vehicles are cobbled together over an elaborate production system that involves both US factories as well as those located in America’s neighbors to the north and south.

But as far as General Motors is concerned, the tumble only underscores what a remarkable run the stock has had recently.

Just a year ago, the stock was getting battered as the company faced challenges galore. First, GM was — along with competitors Ford and Stellantis — enmeshed in contract negotiations with the UAW. Meanwhile, its troubled Cruise self-driving vehicle unit paused operations after losing some licenses to operate in California when one of its robotaxis severely injured a woman. And sales of EVs — an area where Ford and GM had spent billions to retool factories and produce batteries and other components — were slowing.

But since then, GM shares have surged, outpacing not only age-old rival Ford, but also Tesla.

The reason? Profits. The company is within spitting distance of record operating profits, thanks to solid sales of its traditional bread-and-butter offerings of gasoline powered SUVs and pick-up trucks.

But on top of that, it seems that CEO Mary Barra’s strategy of slowly entering the electric car market is bearing fruit, as the New York Times Neil Boudette reported in October:

Sales of G.M.’s battery-powered models are starting to surge as the company begins to reap its big investments in standardized batteries and new factories. Ford's three electric models, including the F-150 Lightning pickup truck and a Transit van, are still selling well but are racking up billions of dollars of losses.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets
Luke Kawa

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.